The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Maximizing productivity of CHO cell‐based fed‐batch culture using chemically defined media conditions and typical manufacturing equipment
Abstract
A highly productive chemically defined fed‐batch process was developed to maximize titer and volumetric productivity for Chinese hamster ovary cell‐based recombinant protein manufacturing. Two cell lines producing a recombinant antibody (cell line A) and an Fc‐fusion protein (cell line B) were used for development. Both processes achieved product titers of 10 g/L on day 18 under chemically defined conditions. For cell line B, the use of plant derived hydrolysates combined with the optimized chemically defined medium increased the titer to 13 g/L. Volumetric productivities were increased from a base line of about 200 mg/L/d to about 500 mg/L/d under chemically defined conditions and as high as 700 mg/L/d with cell line B using plant derived hydrolysates. Peak cell densities reached greater than 20E6 vc/mL, and cell viabilities were maintained above 80% on day 18 without the use of antiapoptotic genes or temperature shift. A rapid compound screening method was developed to effectively test positive factors within 72 h. Peak volumetric oxygen uptake rates (OUR) more than tripled from the baseline condition. Oxygen demand continued to increase after maximum cell density was reached with a maximal OUR of 3.7 mmol/L/h. The new process format was scaled up and verified at 100 L pilot scale using reactor equipment of similar configuration as used at manufacturing scale. © 2010 American Institute of Chemical Engineers Biotechnol. Prog., 2010
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Production of recombinant protein therapeutics in cultivated mammalian cells
Wurm, F. M. (2004) · Nature Biotechnology · doi:10.1038/nbt1026 · Cited by 2,032
Industrial choices for protein production by large-scale cell culture
Chu, L., & Robinson, D. K. (2001) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(00)00197-x · Cited by 547
Cleland, J. L., Powell, M., & Shire, S. J. (1993) · PubMed · Cited by 543
Iscove, N. N., & Melchers, F. (1978) · The Journal of experimental medicine · doi:10.1084/jem.147.3.923 · Cited by 531
Birch, J. R., & Racher, A. J. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.12.006 · Cited by 471
Reactor Engineering in Large Scale Animal Cell Culture
Nienow, A. W. (2006) · Cytotechnology · doi:10.1007/s10616-006-9005-8 · Cited by 433 · cited 1×
“Typical stirred tank reactor systems used in the industry for mammalian cell culture featured mass transfer coefficients (kLa) in the order of 5–15 h 1 depending on power per volume used and the aeration strategy applied.(48) When a culture is maintained at 30% air saturation with the use of pure oxygen, the OTR achie…”
MethodProcess economics of industrial monoclonal antibody manufacture
Farid, S. S. (2007) · Journal of Chromatography B · doi:10.1016/j.jchromb.2006.07.037 · Cited by 389
[5] Media and growth requirements
Ham, R. G., & McKeehan, W. L. (1979) · Methods in Enzymology · doi:10.1016/s0076-6879(79)58126-9 · Cited by 333
Robinson, N. E., & Robinson, A. B. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.221463198 · Cited by 287
Influence of low temperature on productivity, proteome and protein phosphorylation of CHO cells
Kaufmann, H., Mazur, X., Fussenegger, M., & Bailey, J. E. (1999) · Biotechnology and Bioengineering · doi:10.1002/(sici)1097-0290(19990605)63:5<573::aid-bit7>3.0.co;2-y · Cited by 278
Scale‐up analysis for a CHO cell culture process in large‐scale bioreactors
Xing, Z., Kenty, B. M., Li, Z. J., & Lee, S. S. (2009) · Biotechnology and Bioengineering · doi:10.1002/bit.22287 · Cited by 228
Stability of protein production from recombinant mammalian cells
Barnes, L. M., Bentley, C. M., & Dickson, A. J. (2003) · Biotechnology and Bioengineering · doi:10.1002/bit.10517 · Cited by 222
Therapeutic antibody expression technology
Chadd, H. E., & Chamow, S. M. (2001) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(00)00198-1 · Cited by 204
B cells as therapeutic targets in autoimmune neurological disorders
Dalakas, M. C. (2008) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0901 · Cited by 202
Zhu, M. M., Goyal, A., Rank, D. L., Gupta, S. K., Boom, T. V., & Lee, S. S. (2008) · Biotechnology Progress · doi:10.1021/bp049815s · Cited by 199
Effects of temperature shift on cell cycle, apoptosis and nucleotide pools in CHO cell batch cultues
Moore, A., Mercer, J., Dutina, G., Donahue, C. J., Bauer, K. D., Mather, J. P., Etcheverry, T., & Ryll, T. (1997) · Cytotechnology · doi:10.1023/a:1007919921991 · Cited by 191
Self-citationAl-Rubeai, M., & Singh, R. P. (1998) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(98)80108-0 · Cited by 161
Ramirez, O. T., & Mutharasan, R. (1990) · Biotechnology and Bioengineering · doi:10.1002/bit.260360814 · Cited by 160
Gawlitzek, M., Ryll, T., Lofgren, J., & Sliwkowski, M. B. (2000) · Biotechnology and Bioengineering · doi:10.1002/(sici)1097-0290(20000620)68:6<637::aid-bit6>3.0.co;2-c · Cited by 158
Self-citationMa, N., Koelling, K. W., & Chalmers, J. J. (2002) · Biotechnology and Bioengineering · doi:10.1002/bit.10387 · Cited by 153
Semler, E. J., Ranucci, C. S., & Moghe, P. V. (2000) · Biotechnology and Bioengineering · doi:10.1002/1097-0290(20000820)69:4<440::aid-bit10>3.0.co;2-0 · Cited by 132
Fed-batch culture of recombinant NS0 myeloma cells with high monoclonal antibody production
Zhou, W., Chen, C.-C., Buckland, B. C., & Aunins, J. G. (1997) · Biotechnology and Bioengineering · doi:10.1002/(sici)1097-0290(19970905)55:5<783::aid-bit8>3.0.co;2-7 · Cited by 125
Stoichiometric analysis of animal cell growth and its application in medium design
Xie, L., & Wang, D. I. C. (1994) · Biotechnology and Bioengineering · doi:10.1002/bit.260431122 · Cited by 123
The “Push-to-Low” Approach for Optimization of High-Density Perfusion Cultures of Animal Cells
Konstantinov, K., Goudar, C. T., Ng, M. R. A. V., Meneses, R., Thrift, J., Chuppa, S., Matanguihan, C., Michaels, J., & Naveh, D. (2006) · Advances in biochemical engineering, biotechnology · doi:10.1007/10_016 · Cited by 120
Fermentability of the hemicellulose-derived sugars from steam-exploded softwood (douglas fir)
Boussaid, A., Robinson, J., Cai, Y.-J., Gregg, D. J., & Saddler, J. N. (1999) · Biotechnology and Bioengineering · doi:10.1002/(sici)1097-0290(19990805)64:3<349::aid-bit11>3.0.co;2-v · Cited by 117
Ruffieux, P.-A., von Stockar, U., & Marison, I. W. (1998) · Journal of Biotechnology · doi:10.1016/s0168-1656(98)00046-7 · Cited by 114
Strategies for Improved dCO 2 Removal in Large‐Scale Fed‐Batch Cultures
Mostafa, S. S., & Gu, X. (. (2003) · Biotechnology Progress · doi:10.1021/bp0256263 · Cited by 113 · cited 2×
“Mostafa and Gu (2003) reported a 1:1 ratio of air to oxygen aeration rate in a 1,000 L bioreactor run.(52)”
BackgroundInfluentialRecombinant antibodies for cancer diagnosis and therapy
Souriau, C., & Hudson, P. J. (2003) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.3.2.305 · Cited by 111
Biochemistry of growth inhibition by ammonium ions in mammalian cells
Ryll, T., Valley, U., & Wagner, R. (1994) · Biotechnology and Bioengineering · doi:10.1002/bit.260440207 · Cited by 109
Self-citationEffects of Methotrexate on Transfected DNA Stability in Mammalian Cells
Pallavicini, M. G., DeTeresa, P. S., Rosette, C., Gray, J. W., & Wurm, F. M. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.1.401 · Cited by 101
Chiang, G. G., & Sisk, W. P. (2005) · Biotechnology and Bioengineering · doi:10.1002/bit.20551 · Cited by 96
Effect of Ammonia on the Glycosylation of Human Recombinant Erythropoietin in Culture
Yang, M., & Butler, M. (2000) · Biotechnology Progress · doi:10.1021/bp000090b · Cited by 85
Oxygen limitation is a pitfall during screening for industrial strains
Zimmermann, H. F., Anderlei, T., Büchs, J., & Binder, M. (2006) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-006-0414-6 · Cited by 80
Culture of human tumor infiltrating lymphocytes in hollow fiber bioreactors
Knazek, R. A., Wu, Y.-W., Aebersold, P. M., & Rosenberg, S. A. (1990) · Journal of Immunological Methods · doi:10.1016/0022-1759(90)90337-u · Cited by 71
Stratton, L. P., Kelly, R. M., Rowe, J. H., Shively, J. E., Smith, D. D., Carpenter, J. F., & Manning, M. C. (2001) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.1165 · Cited by 59
Zhang, J., Robinson, D., & Salmon, P. M. (2006) · Biotechnology and Bioengineering · doi:10.1002/bit.21081 · Cited by 58
Identification of novel small molecule enhancers of protein production by cultured mammalian cells
Allen, M. J., Boyce, J. P., Trentalange, M. T., Treiber, D. L., Rasmussen, B., Tillotson, B., Davis, R., & Reddy, P. (2008) · Biotechnology and Bioengineering · doi:10.1002/bit.21839 · Cited by 54
Decreased pCO2 accumulation by eliminating bicarbonate addition to high cell‐density cultures
Goudar, C. T., Matanguihan, R. M., Long, E., Cruz, C., Zhang, C., Piret, J. M., & Konstantinov, K. B. (2006) · Biotechnology and Bioengineering · doi:10.1002/bit.21116 · Cited by 51
Meuwly, F., Weber, U., Ziegler, T. R., Gervais, A., Mastrangeli, R., Crisci, C., Rossi, M., Bernard, A., von Stockar, U., & Kadouri, A. (2005) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2005.10.013 · Cited by 50
Improving Performance of Mammalian Cells in Fed‐Batch Processes through “Bioreactor Evolution”
Prentice, H. L., Ehrenfels, B. N., & Sisk, W. P. (2007) · Biotechnology Progress · doi:10.1021/bp060296y · Cited by 44
Amplification and expression of recombinant genes in serum‐independent Chinese hamster ovary cells
Gandor, C. R., Leist, C., Fiechter, A., & Asselbergs, F. A. M. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)01328-8 · Cited by 41
Nivitchanyong, T., Martinez, A., Ishaque, A., Murphy, J. E., Konstantinov, K., Betenbaugh, M. J., & Thrift, J. (2007) · Biotechnology and Bioengineering · doi:10.1002/bit.21479 · Cited by 40
Takuma, S., Hirashima, C., & Piret, J. M. (2007) · Biotechnology and Bioengineering · doi:10.1002/bit.21376 · Cited by 35
Gawlitzek, M., Papac, D. I., Sliwkowski, M. B., & Ryll, T. (1999) · Glycobiology · doi:10.1093/glycob/9.2.125 · Cited by 35
Self-citationSchoenherr, I., Stapp, T. R., & Ryll, T. (2000) · Biotechnology Progress · doi:10.1021/bp000074e · Cited by 31
Self-citationOptimization of High Cell Density Perfusion Bioreactors
Kompala, D. S., & Ozturk, S. S. (2005) · CRC Press eBooks · doi:10.1201/9780849351068-14 · Cited by 23
van de Goor, J. (2004) · Cell engineering · doi:10.1007/1-4020-2217-4_8 · Cited by 4
Cited by
Mammalian cell protein expression for biopharmaceutical production
Zhu, J. (2012) · Biotechnology Advances · doi:10.1016/j.biotechadv.2011.08.022 · Cited by 491
Advances in recombinant antibody manufacturing
Kunert, R., & Reinhart, D. (2016) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-016-7388-9 · Cited by 417
O’Flaherty, R., Bergin, A., Flampouri, E., Mota, L. M., Obaidi, I., Quigley, A., Xie, Y., & Butler, M. (2020) · Biotechnology Advances · doi:10.1016/j.biotechadv.2020.107552 · Cited by 277
Ritacco, F. V., Wu, Y., & Khetan, A. (2018) · Biotechnology Progress · doi:10.1002/btpr.2706 · Cited by 273
Platforms for Production of Protein-Based Vaccines: From Classical to Next-Generation Strategies
Cid, R., & Bolívar, J. (2021) · Biomolecules · doi:10.3390/biom11081072 · Cited by 176
Metadata
- Authors
- Huang, Y., Hu, W., Rustandi, E., Chang, K., Yusuf‐Makagiansar, H., & Ryll, T.
- Venue
- Biotechnology Progress
- Publisher
- Wiley
- Published
- 2010-04-22
- Volume
- 26
- Issue
- 5
- Pages
- 1400-1410
- ISSN
- 1520-6033 (ISSN-L)
- 8756-7938
- OpenAlex
- W2029878671
- Cited by
- 350
- References
- 47
- FWCI
- 6.38
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.